sobuzoxane has been researched along with Cancer of Skin in 2 studies
sobuzoxane: used in treatment of leukemia L1210
| Excerpt | Relevance | Reference |
|---|---|---|
| " at the dose of 1,200 mg/body/day initially, and the dosage was modified thereafter depending on the grade of leukopenia." | 5.28 | [Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases]. ( Arimura, T; Fukuda, M; Katayama, K; Watanabe, H, 1991) |
| " at the dose of 1,200 mg/body/day initially, and the dosage was modified thereafter depending on the grade of leukopenia." | 1.28 | [Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases]. ( Arimura, T; Fukuda, M; Katayama, K; Watanabe, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, Y | 1 |
| Fukuhara, Y | 1 |
| Nagatani, T | 1 |
| Kanzaki, A | 1 |
| Mae, KI | 1 |
| Irisawa, R | 1 |
| Harada, K | 1 |
| Umebayashi, Y | 1 |
| Tsuboi, R | 1 |
| Fukuda, M | 1 |
| Arimura, T | 1 |
| Katayama, K | 1 |
| Watanabe, H | 1 |
2 other studies available for sobuzoxane and Cancer of Skin
| Article | Year |
|---|---|
Low-Dose MST-16/VP-16 Combination Chemotherapy in 9 Patients with Tumor Stage Mycosis Fungoides.
Topics: Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle A | 2022 |
[Complete response provided by new antitumor agent, MST-16 (sobuzoxane), in a breast cancer with multiple cutaneous metastases].
Topics: Adenocarcinoma, Papillary; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Female; Humans; | 1991 |